Videos
Advanced Ovarian Cancer
HER2+ BC: Residual Disease After Neoadjuvant Therapy
Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Early HER2+ Breast Cancer
Multiple Myeloma
Noopur Raje, MD, discusses the current treatment options for patients diagnosed with multiple myeloma. At this time, a number of FDA-approved drugs and different combinations are available.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Longitudinal Data Shapes Our Understanding of High-Risk Multiple Myeloma
2
Atezolizumab Elicits Durable Responses in R/R Extranodal NK/T-Cell Lymphoma
3
How the Immune System Drives Nerve Growth in TNBC
4
FDA Grants Breakthrough Device Designation to Blood-Based Lung Cancer Screening
5